|
Human immunodeficiency virus Articles
Human immunodeficiency virus News : Aethlon Medical Announces Second HIV/AIDS Treatment Site Thu, 03 Jul 2008 17:38:54 GMT Acquired Immune Deficiency Syndrome (AIDS) is a global epidemic threatening the lives of millions of people. Because there is no known cure, prevention of the transmission of the virus that causes AIDS, the Human Immunodeficiency Virus (HIV), is critical for controlling the disease.Human immunodeficiency virus News : Since introduction of highly active antiretroviral therapy, HIV death rate has decreased Tue, 01 Jul 2008 20:24:46 GMT A number of studies have reported the dramatic decreases in mortality among individuals infected with human immunodeficiency virus (HIV) since the widespread introduction of highly active antiretroviral therapy (HAART) in industrialized countries.Scientists tweak cell, hold out HIV hope Mon, 30 Jun 2008 21:17:13 GMT New Delhi, June 30: Researchers have engineered the surface of white blood cells to make them resistant to the human immunodeficiency virus (HIV), kindling hopes of a new and long-lasting treatment for HIV.Aethlon Medical Announces Second HIV/AIDS Treatment Site Tue, 01 Jul 2008 14:16:58 GMT Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India. Aethlon previously disclosed plans to initiate the "first-in-man" clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV), which causes Acquired Immune Deficiency Syndrome (AIDS). The Aethlon Hemopurifier(R) is a medical ...Sexually transmitted diseases: Education is essential Mon, 30 Jun 2008 08:19:22 GMT The headlines read: "Teen pregnancy is on the increase" and "HIV spikes in men who have sex with men." HIV (human immunodeficiency virus) cases have climbed 12 percent among the group of U.S. boys and men ages 13 to 24, increasing most among ethnic minorities.Diagnostic HYBRIDS Receives Third Frontier Grant For Development Of Assays To Monitor Drug Resistance And Vaccine ... Mon, 30 Jun 2008 10:12:52 GMT Diagnostic HYBRIDS has received funding through the Biomedical Research Commercialization Program (BRCP) to develop more sensitive and affordable assays for the monitoring of patients infected with Human Immunodeficiency Virus (HIV) and/or Hepatitis C Virus (HCV) and to produce vaccines against influenza virus.Pregnant women to be offered free HIV screening Sun, 29 Jun 2008 22:19:24 GMT From July 1 pregnant women in Hawkeâs Bay will be offered free Human Immunodeficiency Virus (HIV) screening to reduce the risk of the infection being passed to their baby.Health officials boost HIV testing Sat, 28 Jun 2008 08:17:48 GMT Physicians should offer HIV testing as a standard part of routine exams, Orange County health officials said Friday during a news conference in Orlando kicking off National HIV Testing Day. Human immunodeficiency virus tests should be as customary as annual mammograms, said Dr. Kevin Sherin, director of the Orange County Health Department. Nationally, Florida ranks third in the total number of ...Diagnostic HYBRIDS Receives Third Frontier Grant for Development of Assays to Monitor Drug Resistance and Vaccine ... Fri, 27 Jun 2008 14:56:36 GMT Diagnostic HYBRIDS has received funding through the Biomedical Research Commercialization Program (BRCP) to develop more sensitive and affordable assays for the monitoring of patients infected with Human Immunodeficiency Virus (HIV) and/or Hepatitis C Virus (HCV) and to produce vaccines against influenza virus. The BRCP is part of the Third Frontier Project, a push by Ohio lawmakers to bring ...Infant formula blocks HIV transmission via breastfeeding Thu, 03 Jul 2008 16:37:18 GMT Toronto, ON, Canada - Acquired Immune Deficiency Syndrome (AIDS) is a global epidemic threatening the lives of millions of people.New System Blocks HIV Transmission Via Breastfeeding Thu, 03 Jul 2008 17:22:05 GMT Researchers are developing a new technology that prevents the infection of HIV by breastfeeding. Ardea reports positive results of phase IIa study of lead HIV candidate RDEA806 Fri, 27 Jun 2008 10:01:39 GMT Ardea Biosciences has announced additional positive results from its completed phase IIa proof-of-concept monotherapy study of RDEA806, its novel investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in patients with human immunodeficiency virus (HIV).Wyeth and Progenics Receive Approval from European Commission for RELISTOR for Opioid-Induced Constipation in Advanced ... Thu, 03 Jul 2008 17:17:57 GMT Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the companies have received marketing approval for RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection from the European Commission. RELISTOR is now approved in the 27 member states of the European Union as well as Iceland, Norway, and Liechtenstein for the ...Since Introduction Of Highly Active Antiretroviral Therapy, HIV Death Rate Has Decreased Wed, 02 Jul 2008 21:20:12 GMT In industrialized countries, persons infected sexually with HIV now appear to experience mortality rates similar to those of the general population in the first 5 years following infection, though a higher risk of death remains as the duration of HIV infection lengthens, according to a new study. Flood warning system funding approved Thu, 03 Jul 2008 13:17:55 GMT WASHINGTON, DC â Congressman Maurice Hinchey (D-NY) and Congressman John Hall (D-NY) have secured the House Appropriations Committeeâs approval of $835,000 for the continuation of a flood mitigation study in the Upper Delaware River Watershed and for the development of a flood alert system for the region.Wyeth and Progenics Receive Approval from European Commission for RELISTOR for Opioid-Induced Constipation in Advanced ... Thu, 03 Jul 2008 16:57:00 GMT COLLEGEVILLE, Pa., & TARRYTOWN, N.Y.----Wyeth Pharmaceuticals, a division of Wyeth , and Progenics Pharmaceuticals, Inc. , today announced that the companies have received marketing approval for RELISTOR⢠subcutaneous injection from the European Commission.HIV Day encourages testing, preventing risks Wed, 02 Jul 2008 20:45:43 GMT The U.S. Department of Health and Human Services estimates there are more than 1 million people living with HIV in the United States. Of those people infected with the virus, one quarter of them go through their daily lives unaware that they have an infectious disease.Stanislaus civil grand jury: Needle exchange could curb HIV, hepatitis C Wed, 02 Jul 2008 14:13:07 GMT Stanislaus County should create a needle exchange program to reverse a trend of rising hepatitis C infections, the civil grand jury recommended Monday.Free HIV Testing Across Virginia Friday (11:48 pm) Fri, 27 Jun 2008 03:52:01 GMT RICHMOND, Va. (AP) - Facilities throughout Virginia are offering free or discounted HIV testing on Friday in observance of National HIV Testing Day. The Virginia Department of Health says the state ranked tenth in 2005 for the most annually reported cases of human immunodeficiency virus in the U.S. HIV is the virus that attacks the immune system and causes AIDS. It can be transmitted sexually ...Cells in blood may help cancers spread Tue, 01 Jul 2008 20:24:00 GMT Normal cells in the blood that play a role in healing wounds may also be creating the right conditions for cancer cells to spread, U.S. researchers said on Tuesday.Blood cells: Heal wounds, spreads cancer 3 Jul 2008, 0044 hrs IST,REUTERS Wed, 02 Jul 2008 20:04:46 GMT CHICAGO: Normal cells in the blood that play a role in healing wounds may also be creating the right conditions for cancer cells to spread, US researchers said.Since introduction of highly active antiretroviral therapy, HIV death rate has decreased Tue, 01 Jul 2008 20:57:49 GMT In industrialized countries, persons infected sexually with HIV now appear to experience mortality rates similar to those of the general population in the first 5 years following infection, though a higher risk of death remains as the duration of HIV infection lengthens, according to a study in the July 2 issue of JAMA.Mortality Lower For HIV Infected Individuals Since Introduction Of Highly Active Antiretroviral Therapy Tue, 01 Jul 2008 23:12:42 GMT In industrialized countries, HIV positive individuals who acquired the disease sexually experience rates of mortality similar to the general population in the first five years following infection, though the risk of death continues as the duration of the infection becomes longer than this period. These results were published in an article released on July 1, 2008 in JAMA.Cells in blood may help cancers spread - U.S. study Tue, 01 Jul 2008 20:19:55 GMT By Julie SteenhuysenCells in blood may help cancers spread-US study Tue, 01 Jul 2008 20:27:07 GMT Source: Reuters By Julie Steenhuysen CHICAGO, July 1 (Reuters) - Normal cells in the blood that play a role in healing wounds may also be creating the right conditions for cancer cells to spread, U.S. researchers ... 5 things you didn't know about metatarsalgia Tue, 01 Jul 2008 07:22:44 GMT 1 Problem: This condition, which is not generally serious, causes pain and inflammation in the balls of the feet, especially when walking barefoot on a hard surface. Some people might experience numbness or tingling in the toes.Geneombio to foray into research, molecular diagnostic kits business Tue, 01 Jul 2008 02:47:10 GMT The Pune-based Geneombio Technologies Pvt Ltd, a contract research organization specialized in providing extensive customized DNA-based service in the areas of human, livestock health and agriculture, is all set to launch its molecular diagnostics and research kits business with a range of products within a month.Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating The Use Of Zinc Finger Nucleases To Generate ... Tue, 01 Jul 2008 09:14:42 GMT Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by treatment with zinc finger DNA-binding protein nucleases (ZFN(TM)).Pharmasset Joins Russell 3000 Index Tue, 01 Jul 2008 12:59:00 GMT Pharmasset, Inc. joined the broad-market Russell 3000® Index when Russell Investments reconstituted its equity indexes on June 27.Sangamo's Gene Technique May Save AIDS-Fighting Immune Cells Sun, 29 Jun 2008 17:31:27 GMT June 29 (Bloomberg) -- Sangamo Biosciences Inc. 's gene technique can protect infection-fighting cells from the AIDS virus, according to a study in mice.Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate ... Mon, 30 Jun 2008 11:00:00 GMT Sangamo BioSciences, Inc. announced today the publication of data demonstrating that human immune system cells can be made resistant to HIV infection by treatment with zinc finger DNA-binding protein nucleases (ZFN).Free HIV testing helps Central Oregonians Sat, 28 Jun 2008 06:22:08 GMT National HIV Testing Day is an opportunity for people to learn their HIV status, and to gain knowledge to take control of their health and their lives.ARE urges HIV testing every day Sat, 28 Jun 2008 04:58:10 GMT Winchester â AIDS Response Effort of Winchester marked National HIV Testing Day on Friday the same way it marks every day â by waiting for residents to get a test for HIV.Health clinics urge HIV testing Fri, 27 Jun 2008 12:50:53 GMT Friday is national HIV Testing Day, and local health departments are spreading the word about the services they offer. The National Association of People with AIDS' annual campaign is designed to encourage at-risk people to seek HIV testing and counseling.HIV/AIDS cases rise in older people Fri, 27 Jun 2008 09:54:10 GMT The number of people older than 50 infected with HIV is rising across the state and the nation, say experts who worry seniors think they are not at risk for the virus. Free HIV testing to be available Fri, 27 Jun 2008 11:37:44 GMT The Brazos County Health Department will administer free HIV tests from 1 to 4 p.m. Monday. The event is in recognition of National HIV Te ... Saving more Filipinos from diseases Fri, 27 Jun 2008 21:35:43 GMT MANILA, PhilippinesâEach year, millions of children and adults in developing countries die from diseases that could have been prevented by vaccines that readily available today.HIV could be 'slashed with counselling' Fri, 27 Jun 2008 00:08:13 GMT HIV infections among heterosexual Africans could be slashed by a third if safe-sex counselling was directed at married or cohabiting couples, a study says.HIV could be 'slashed with counselling' Fri, 27 Jun 2008 00:40:36 GMT HIV infections among heterosexual Africans could be slashed by more than a third if safe-sex counselling was directed at married or cohabiting couples, a new study says.Aethlon CEO Discusses "First-In-Man" HIV Study On CEOcast Fri, 27 Jun 2008 09:14:52 GMT Aethlon Medical, Inc. (OTCBB:AEMD) disclosed this evening that its CEO, James A. Joyce, is currently featured in an on-line interview with CEOcast, Inc. During the interview, Mr. Joyce discusses the "first-in-man" clinical study of the Aethlon Hemopurifier® as a treatment for HIV/AIDS.Aethlon Medical Featured in Medical Device Daily Fri, 27 Jun 2008 11:45:38 GMT Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that it has been featured in a cover story published in Medical Device Daily. The story is accessible online at: www.aethlonmedical.com/pdfs/mdd062508.pdfINTELENCE(TM) (etravirine) Receives Positive Opinion From European Committee for Human Medicinal Products (CHMP) for ... Fri, 27 Jun 2008 06:22:27 GMT Cork, Ireland (ots/PRNewswire) - - INTELENCE is the first NNRTI to demonstrate antiviral activity in patients with NNRTI-resistant virus - Tibotec Pharmaceuticals, ...INTELENCE(TM) (etravirine) Receives Positive Opinion From European Committee for Human Medicinal Products (CHMP) for ... Fri, 27 Jun 2008 06:16:27 GMT Cork, Ireland (ots/PRNewswire) - - INTELENCE is the first NNRTI to demonstrate antiviral activity in patients with NNRTI-resistant virus - Tibotec Pharmaceuticals, Ltd. announced today that the Committee for Human Medicinal ...INTELENCE(TM) (etravirine) Receives Positive Opinion Fro. Fri, 27 Jun 2008 06:16:15 GMT Tibotec Pharmaceuticals, Ltd. announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending conditional approval of its HIV medication INTELENCE(TM) (etravirine) in the European Union.Know your HIV status, health advocates say; free testing offered Fri, 27 Jun 2008 04:15:19 GMT Local public health advocates are encouraging anyone who doesnât know his or her HIV status to find out. |
Infectious and parasitic diseases |
|
|
< Home > |
||